Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (631-640 of 726) with videos related to

Pageof 73
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2011
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptorsS Grimwood, Y Lu, A W Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapseL E Robertson, J R Redman, J J Butler, et al.
BMJ (Clinical Research Ed.)|October 19, 2005
Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after studyShane Allwright, Gillian Paul, Birgit Greiner, et al.
ACS Combinatorial Science|December 15, 2015
Direct Phenotypic Screening in Mice: Identification of Individual, Novel Antinociceptive Compounds from a Library of 734,821 Pyrrolidine Bis-piperazinesRichard A Houghten, Michelle L Ganno, Jay P McLaughlin, et al.
Allergy and Asthma Proceedings|December 10, 2016
A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climatesJulia A Wisniewski, Anne P McLaughlin, Philip J Stenger, et al.
The Science of the Total Environment|May 31, 2001
Integrated natural radiation exposure studies in stable Yugoslav rural communitiesZ S Zunic, J P McLaughlin, C Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphomaB Esmaeli, P McLaughlin, B Pro, et al.
Journal of Helminthology|January 6, 2012
Digenean metacercariae of fishes from the lagoon flats of Palmyra Atoll, Eastern Indo-PacificV M Vidal-Martínez, M L Aguirre-Macedo, J P McLaughlin, et al.
The AAPS Journal|July 22, 2020
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In VivoSebastiano Intagliata, Abhisheak Sharma, Tamara I King, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC seriesA López-Guillermo, F Cabanillas, P McLaughlin, et al.
Pageof 73

Showing results (631-640 of 726) with videos related to

Sort By:
Pageof 73
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2011
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptorsS Grimwood, Y Lu, A W Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapseL E Robertson, J R Redman, J J Butler, et al.
BMJ (Clinical Research Ed.)|October 19, 2005
Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after studyShane Allwright, Gillian Paul, Birgit Greiner, et al.
ACS Combinatorial Science|December 15, 2015
Direct Phenotypic Screening in Mice: Identification of Individual, Novel Antinociceptive Compounds from a Library of 734,821 Pyrrolidine Bis-piperazinesRichard A Houghten, Michelle L Ganno, Jay P McLaughlin, et al.
Allergy and Asthma Proceedings|December 10, 2016
A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climatesJulia A Wisniewski, Anne P McLaughlin, Philip J Stenger, et al.
The Science of the Total Environment|May 31, 2001
Integrated natural radiation exposure studies in stable Yugoslav rural communitiesZ S Zunic, J P McLaughlin, C Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphomaB Esmaeli, P McLaughlin, B Pro, et al.
Journal of Helminthology|January 6, 2012
Digenean metacercariae of fishes from the lagoon flats of Palmyra Atoll, Eastern Indo-PacificV M Vidal-Martínez, M L Aguirre-Macedo, J P McLaughlin, et al.
The AAPS Journal|July 22, 2020
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In VivoSebastiano Intagliata, Abhisheak Sharma, Tamara I King, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC seriesA López-Guillermo, F Cabanillas, P McLaughlin, et al.
Pageof 73